Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

6 Jun 2024 07:00

RNS Number : 3865R
Athelney Trust PLC
06 June 2024
 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 195.1p at 31 May 2024.

Fund Manager's comment for May 2024

The US economy expanded at an annualized rate of only 1.3% in the first quarter of 2024, on the back of slowing consumer spending on both goods and services in response to the high interest rates. By comparison, the British economy grew by 0.6% in the first three months of 2024, ending the recession it entered last year which marks the strongest expansion in over two years. In expenditure terms, household consumption went up 0.2%, led by spending on housing, water and fuels, recreation and culture, restaurants and hotels. Retail sales fell 2.3% between March and April, with fewer purchases in clothing and furniture stores.

Recent US inflation data did not show any "meaningful progress" but it is at least consistent with cooling price growth and leaves the door open for cuts later in the year. In the UK, core inflation at 3.9% was down from 4.2% the previous month.  The picture was much the same in Europe with a 4.9% increase in the pace of labor costs. However, what is evident is that global inflation is coming down from the 2022 peak.

In terms of the international economic outlook, May PMI surveys for the Eurozone and United Kingdom pointed to a continuing recovery for those key European economies. In the UK, the manufacturing PMI rose to the highest level since July 2022, while the services PMI remained in expansion territory for the seventh month in a row.

The stock market declines that were reported in April were for the most part reversed in May. The S&P500 increased by 4.8% following a 4.2% decline in April as did the NASDAQ, increasing by 6.9% after a 4.4% decline with the MSCI up by 4.2% after being down by 3.9% in the previous month. 

The UK markets continued their positive performance this year with the FTSE 100 up by 1.61% and the broad index, the FTSE 250 up by 3.83%. The Small Cap Index was up by 4.08%, the AIM All-Share index up by 5.92% and the Fledgling Index up by 3.96%.

With the exception of Impax Asset Management, the Athelney portfolio of stocks performed well during the month with the portfolio value increasing by 3.38%. Impax is one of our largest positions, declining by 14.7% on the day when the company announced that there had been a material outflow from the BNP Paribas mandate. This decision by BNP Paribas to withdraw the funds reflects a decision made by them to meet their own business requirements, asset allocation targets or outflows from their distribution network and is in no way is a reflection on the Impax business. In fact, Impax AUM was up by £2.2bn or 6% during the past six months, reaching £39.6bn on 31 Mar 24 (30 Sep 23: £37.4bn) and exceeding that of two thirds of the London-listed peer group. We expect that the value of this quality business will once again be reflected in the market price.

After TClarke went ex-dividend, we sold our entire holding into the take-over bid and added to our holding in Liontrust and Paypoint.  The net result was that after accounting for expenses, there was an increase in the Athelney NAV of 2.79% for the month while our cash holding declined slightly to 2.7%.

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About" then select "Latest Monthly Fact Sheet".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (license no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has AUD2.7bn (£1.5 billion) under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD95m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD37m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD33m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP6m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is a "Dividend Hero" being one of only a few investment companies that have increased their dividend every year for 20 years or more. See link

https://www.theaic.co.uk/income-finder/dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGUGDLXXGDGSL
Date   Source Headline
25th Jan 201910:08 amRNSDirectorate Change
22nd Jan 20192:52 pmRNSResult of EGM
11th Jan 20193:00 pmRNSEGM Shareholder Statement
4th Jan 201910:26 amRNSNet Asset Value(s)
28th Dec 20184:00 pmRNSNotice of Extraordinary General Meeting
19th Dec 20181:43 pmRNSDirector/PDMR Shareholding
19th Dec 20189:09 amRNSDirector/PDMR Shareholding
17th Dec 201811:28 amRNSStatement re Corporate Action
5th Dec 201810:43 amRNSNet Asset Value(s)
3rd Dec 20189:38 amRNSDirectorate Change
5th Nov 20189:39 amRNSNet Asset Value(s)
3rd Oct 20183:20 pmRNSNet Asset Value(s)
1st Oct 201811:43 amRNSDirectorate Change
5th Sep 201810:54 amRNSNet Asset Value(s)
3rd Aug 20188:30 amRNSNet Asset Value(s)
20th Jul 20187:00 amRNSHalf-year Report
4th Jul 20189:48 amRNSNet Asset Value(s)
25th Jun 20189:15 amRNSChange of Adviser
4th Jun 201812:52 pmRNSNet Asset Value(s)
2nd May 20182:12 pmRNSNet Asset Value(s)
30th Apr 20182:03 pmRNSDirectorate Change
16th Apr 20188:54 amRNSDirector/PDMR Shareholding
9th Apr 201811:35 amRNSNet Asset Value(s)
22nd Mar 201810:14 amRNSAGM Statement
6th Mar 201812:50 pmRNSNet Asset Value(s)
16th Feb 20187:00 amRNSAnnual Financial Report
6th Feb 20189:05 amRNSNet Asset Value(s)
3rd Jan 201810:51 amRNSNet Asset Value(s)
5th Dec 201710:15 amRNSNet Asset Value(s)
2nd Nov 201712:52 pmRNSNet Asset Value(s)
3rd Oct 201711:24 amRNSNet Asset Value(s)
4th Sep 201712:00 pmRNSNet Asset Value(s)
3rd Aug 20178:34 amRNSNet Asset Value(s)
25th Jul 20177:00 amRNSHalf-year Report
5th Jul 201710:59 amRNSNet Asset Value(s)
5th Jul 20179:53 amRNSHolding(s) in Company
5th Jun 20179:51 amRNSNet Asset Value(s)
8th May 20179:20 amRNSNet Asset Value(s)
5th Apr 20179:16 amRNSNet Asset Value(s)
31st Mar 201711:52 amRNSAGM Statement
6th Mar 20179:53 amRNSNet Asset Value(s)
24th Feb 20177:00 amRNSAnnual Financial Report
3rd Feb 201712:17 pmRNSNet Asset Value(s)
6th Jan 20178:54 amRNSNet Asset Value(s)
5th Dec 20169:13 amRNSNet Asset Value(s)
3rd Nov 20168:45 amRNSNet Asset Value(s)
4th Oct 20169:34 amRNSNet Asset Value(s)
21st Sep 20169:44 amRNSDirector/PDMR Shareholding
2nd Sep 201612:35 pmRNSNet Asset Value(s)
2nd Aug 20168:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.